U.S. markets open in 2 hours 47 minutes
  • S&P Futures

    3,845.75
    +36.50 (+0.96%)
     
  • Dow Futures

    31,182.00
    +270.00 (+0.87%)
     
  • Nasdaq Futures

    13,068.50
    +157.50 (+1.22%)
     
  • Russell 2000 Futures

    2,242.50
    +43.30 (+1.97%)
     
  • Crude Oil

    62.21
    +0.71 (+1.15%)
     
  • Gold

    1,740.50
    +11.70 (+0.68%)
     
  • Silver

    26.87
    +0.43 (+1.63%)
     
  • EUR/USD

    1.2045
    -0.0042 (-0.35%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    25.24
    -3.65 (-12.63%)
     
  • GBP/USD

    1.3963
    +0.0041 (+0.29%)
     
  • USD/JPY

    106.7250
    +0.2230 (+0.21%)
     
  • BTC-USD

    47,706.66
    +2,378.71 (+5.25%)
     
  • CMC Crypto 200

    959.53
    +26.40 (+2.83%)
     
  • FTSE 100

    6,568.78
    +85.35 (+1.32%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

LOS ANGELES, Feb. 1, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the securities laws.

(PRNewsfoto/The Schall Law Firm)
(PRNewsfoto/The Schall Law Firm)

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Sarepta announced that its one-time gene therapy for Duchenne muscular dystrophy failed to show patient benefits as compared to a placebo on January 7, 2021. Based on this news, shares of Sarepta suffered a massive drop on January 8, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/ongoing-investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-sarepta-therapeutics-inc-and-encourages-investors-with-losses-of-100-000-to-contact-the-firm-301219367.html

SOURCE The Schall Law Firm